NRx Pharmaceuticals, Inc.

NasdaqGM:NRXP Stock Report

Mkt Cap: US$82.5m

NRx Pharmaceuticals Future Growth

How is NRx Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


10.7%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

Earnings and Revenue Growth Forecasts

NasdaqGM:NRXP - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2023N/AN/AN/A-222
9/30/2022N/A-316-43-43N/A
6/30/2022N/A-88-48-48N/A
3/31/2022N/A-337-45-45N/A
12/31/2021N/A-349-38-38N/A
9/30/2021N/A-108-27-27N/A
6/30/2021N/A-76-16-16N/A
3/31/2021N/A-76-4-4N/A
12/31/2020N/A-52-2-2N/A
9/30/2020N/A-8-3-3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if NRXP's forecast earnings growth is above the savings rate (2%).

Earnings vs Market: Insufficient data to determine if NRXP's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if NRXP's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if NRXP's revenue is forecast to grow faster than the US market.

High Growth Revenue: NRXP is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if NRXP's Return on Equity is forecast to be high in 3 years time


Discover growth companies